Chargement en cours...
Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma
PURPOSE: Systemic therapy has improved rhabdomyosarcoma event-free and overall survival; however, approximately 40 % of patients will have progressive or recurrent disease which is difficult to cure and remains a considerable challenge. Minimal progress has been made in improving outcomes for metast...
Enregistré dans:
| Publié dans: | Cancer Chemother Pharmacol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965487/ https://ncbi.nlm.nih.gov/pubmed/27324022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-016-3077-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|